Pamir Ozan
SEC insider (Form 3/4/5 filer). CIK 0001834681. Chief Financial Officer at Niagen Bioscience, Inc. (NAGE). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in LOS ANGELES, CA.
Companies Pamir Ozan has filed insider reports for
- Niagen Bioscience, Inc. (NAGE): Officer, Chief Financial Officer
Pamir Ozan
CIK: 0001834681
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Niagen Bioscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 30, 2026NAGE
Niagen Bioscience, Inc.
AwardDirect4.3K shares at avg. $2.71$12K - Feb 19, 2026NAGE
Niagen Bioscience, Inc.
AwardDirectEmployee Stock Options (right to buy)
62.1K shares- - Nov 14, 2025NAGE
Niagen Bioscience, Inc.
PurchaseIndirect2.2K shares at avg. $6.85$15K - Nov 14, 2025NAGE
Niagen Bioscience, Inc.
PurchaseDirect4.5K shares at avg. $6.81$30K - Feb 12, 2025CDXC
ChromaDex Corp.
AwardDirectEmployee Stock Options (right to buy)
17.2K shares- - Nov 22, 2024CDXC
ChromaDex Corp.
PurchaseDirect2.9K shares at avg. $7.36$21K - Oct 21, 2024CDXC
ChromaDex Corp.
AwardDirectEmployee Stock Options (right to buy)
146.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | NAGE Niagen Bioscience, Inc. | Award | 4,255 | $2.71 | $11,531 | Direct |
| Feb 19, 2026 | NAGE Niagen Bioscience, Inc. | Award Employee Stock Options (right to buy) | 62,131 | - | - | Direct |
| Nov 14, 2025 | NAGE Niagen Bioscience, Inc. | Purchase | 2,220 | $6.85 | $15,210 | Indirect |
| Nov 14, 2025 | NAGE Niagen Bioscience, Inc. | Purchase | 4,465 | $6.81 | $30,406 | Direct |
| Feb 12, 2025 | CDXC ChromaDex Corp. | Award Employee Stock Options (right to buy) | 17,230 | - | - | Direct |
| Nov 22, 2024 | CDXC ChromaDex Corp. | Purchase | 2,907 | $7.36 | $21,397 | Direct |
| Oct 21, 2024 | CDXC ChromaDex Corp. | Award Employee Stock Options (right to buy) | 146,544 | - | - | Direct |
1-7 of 7 transactions